Nicaise Claude
CIK 0001644162
Director
Filings
14
Latest Jan 29, 2026
Issuers covered
4
Showing
14 of 14
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +48.9% | +48.9% | +48.9% | +48.9% |
| 90 days | 1 | 100% | +60.8% | +60.8% | +60.8% | +60.8% |
| 180 days | 1 | 100% | +82.4% | +82.4% | +82.4% | +82.4% |
| 365 days | 1 | 100% | +82.9% | +82.9% | +82.9% | +82.9% |
Issuers
Companies where Nicaise Claude has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | 6 | Jan 29, 2026 |
| SAVA | Cassava Sciences Inc | 3 | May 27, 2025 |
| GANX | Gain Therapeutics, Inc. | 3 | Jun 25, 2025 |
| CMMB | Chemomab Therapeutics Ltd. | 2 | Mar 23, 2023 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|